DelveInsight Drug Report, AcipHex Drug Insights, 2017 highlights the AcipHex marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the AcipHex covering the total sales estimation and also provides the AcipHex sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of AcipHex, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight's Report provides the SWOT analysis for the AcipHex.
Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as uptodate as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.
Scope
A review of the AcipHex based on information derived from company and industryspecific sources
Coverage of the Marketed data of the AcipHex on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
Coverage of the United States Drug Master File US DMF, Active Substance Master File/EU DMF and API Manufactures in China India for AcipHex with location details
Patent Expiry Timeline and Exclusivity Details
Route of Synthesis of the API
Global Forecasted Sales Figure to 2018
Qualitative and quantitative assessment of market space
SWOT Analysis
Reasons to buy
Evaluate the marketing status and exclusivity details of AcipHex to exploit opportunities for generic drug development opportunities.
Design effective counterstrategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to AcipHex.
API intelligence over AcipHex and gaining primary intelligence over Active Ingredients manufacturers across the globe.
Understanding the chemical route of synthesis of AcipHex.
Uncovering opportunities in the rapidly growing the US market
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your MA and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and indepth analysis of the drug's performance
Obtain sales forecast for currently marketed drug for to 2018
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.